Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Edgewise Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +31 vs. Q3 2023
- Shares held
- 79.6M
- +11.2M (+16.4%) vs. Q3 2023
- Total value
- $871.4M
- +$479.2M (+122.2%) vs. Q3 2023
- New holders
- 38
- 43 more added
- Sold out
- 7
- 20 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 1,187,880 | $13.0M | 0.11% | +1,187,880 | New |
| Janus Henderson Group PLC | 1,215,013 | $13.2M | 0.01% | +94,246+8.4% | Added |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $17.0M | 13.69% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,125,380 | $23.3M | 0.00% | +60,959+3.0% | Added |
| Deep Track Capital, LP | 2,537,176 | $27.8M | 0.97% | −212,824−7.7% | Reduced |
| Cormorant Asset Management, LP | 2,551,989 | $27.9M | 1.34% | −394,898−13.4% | Reduced |
| Citadel Advisors LLC | 2,585,930 | $28.3M | 0.03% | −181,506−6.6% | Reduced |
| Frazier Life Sciences Management, L.P. | 2,667,203 | $29.2M | 1.56% | +1,818,181+214.2% | Added |
| Baker Bros. Advisors LP | 3,112,786 | $34.1M | 0.39% | +2,063,087+196.5% | Added |
| BlackRock Inc. | 3,307,110 | $36.2M | 0.00% | +321,266+10.8% | Added |
| EcoR1 Capital, LLC | 3,493,194 | $38.2M | 0.99% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 3,933,137 | $43.0M | 0.79% | 00.0% | Unchanged |
| Novo Holdings A/S | 6,071,703 | $66.4M | 4.44% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,159,146 | $67.4M | 0.25% | 00.0% | Unchanged |
| FMR LLC | 6,492,513 | $71.0M | 0.01% | +89,666+1.4% | Added |
| OrbiMed Advisors LLC | 14,567,176 | $159.4M | 3.19% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −26,023−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −23,715−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −10,384−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −371−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −102−100.0% | Sold out |